Ftse Mib
34.395,62
0,06%
DAX
18.518,03
-0,44%
S&P 500
5.645,27
0,25%
NASDAQ
18.430,00
-0,23%
Bitcoin
64.570,63
-0,43%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Evgen Pharma Plc (EVG) Evgen Pharma Plc (EVG) Notizie

EVG

Evgen Pharma (EVG)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG
DataOraFonteTitoloSimboloCompagnia
22/03/202308:00UK RegulatoryEvgen Pharma PLC Preliminary results from Phase 1b studyLSE:EVGEvgen Pharma Plc
16/03/202317:35Alliance NewsAlliance NewsEvgen notes evidence of radiosensitisation by SFX-01 in cancer cellsLSE:EVGEvgen Pharma Plc
16/03/202315:00UK RegulatoryEvgen Pharma PLC Price Monitoring ExtensionLSE:EVGEvgen Pharma Plc
16/03/202312:05UK RegulatoryEvgen Pharma PLC Second Price Monitoring ExtnLSE:EVGEvgen Pharma Plc
16/03/202308:00RNS Non-RegulatoryEvgen Pharma PLC Further evidence of radiosensitisation by SFX-01LSE:EVGEvgen Pharma Plc
13/03/202313:18Alliance NewsAlliance NewsSUMMARY: London listings with exposure to Silicon Valley BankLSE:EVGEvgen Pharma Plc
13/03/202308:00UK RegulatoryEvgen Pharma PLC No exposure to Silicon Valley BankLSE:EVGEvgen Pharma Plc
25/01/202311:40Alliance NewsAlliance NewsEvgen Pharma completes dosing of clinical trial for SFX-01 tabletLSE:EVGEvgen Pharma Plc
25/01/202308:00UK RegulatoryEvgen Pharma PLC Clinical trial updateLSE:EVGEvgen Pharma Plc
14/12/202218:08UK RegulatoryEvgen Pharma PLC Grant of Options - Director/PDMR ShareholdingLSE:EVGEvgen Pharma Plc
08/12/202214:57Alliance NewsAlliance NewsEvgen Pharma loss, operating expenses widen; SFX-01 study on scheduleLSE:EVGEvgen Pharma Plc
08/12/202208:00UK RegulatoryEvgen Pharma PLC Half-year ReportLSE:EVGEvgen Pharma Plc
02/12/202208:00UK RegulatoryEvgen Pharma PLC Notice of Half Year ResultsLSE:EVGEvgen Pharma Plc
16/11/202217:11Alliance NewsAlliance NewsEvgen Pharma starts clinical trial of new SFX-01 tabletLSE:EVGEvgen Pharma Plc
16/11/202208:00UK RegulatoryEvgen Pharma PLC Study started of new SFX-01 tablet formulationLSE:EVGEvgen Pharma Plc
13/10/202218:55Alliance NewsAlliance NewsCORRECT: Coral Products buys Ecodeck; Evgen Pharma recruitsLSE:EVGEvgen Pharma Plc
12/10/202222:46Alliance NewsAlliance NewsTRADING UPDATES: Coral Products buys Ecodeck; Evgen Pharma recruitsLSE:EVGEvgen Pharma Plc
10/10/202210:58Alliance NewsAlliance NewsEvgen Pharma shares jump 65% as licences SFX-01 composition for autismLSE:EVGEvgen Pharma Plc
10/10/202208:00UK RegulatoryEvgen Pharma PLC SFX-01 licensing deal for up to $160.5mLSE:EVGEvgen Pharma Plc
29/09/202208:00UK RegulatoryEvgen Pharma PLC Regulatory approval for healthy volunteer studyLSE:EVGEvgen Pharma Plc
22/07/202208:00UK RegulatoryEvgen Pharma PLC Result of AGMLSE:EVGEvgen Pharma Plc
14/07/202213:43UK RegulatoryEvgen Pharma PLC Investor PresentationLSE:EVGEvgen Pharma Plc
06/07/202213:25UK RegulatoryEvgen Pharma PLC Notice of AGMLSE:EVGEvgen Pharma Plc
13/06/202220:22Alliance NewsAlliance NewsIN BRIEF: Evgen to work with University of Michigan on asset SFX-01LSE:EVGEvgen Pharma Plc
13/06/202208:00RNS Non-RegulatoryEvgen Pharma PLC Collaboration with University of MichiganLSE:EVGEvgen Pharma Plc
08/06/202215:26Alliance NewsAlliance NewsEvgen Pharma starts trial to test breast cancer tablet; loss narrowsLSE:EVGEvgen Pharma Plc
08/06/202208:01UK RegulatoryEvgen Pharma PLC Full Year ResultsLSE:EVGEvgen Pharma Plc
07/06/202208:01UK RegulatoryEvgen Pharma PLC Notice of ResultsLSE:EVGEvgen Pharma Plc
25/05/202223:02Alliance NewsAlliance NewsTRADING UPDATES: Tekcapital fundraise; Kromek wins US government orderLSE:EVGEvgen Pharma Plc
25/05/202209:31RNS Non-RegulatoryEvgen Pharma PLC Collaboration with Università Sapienza di RomaLSE:EVGEvgen Pharma Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG

La tua Cronologia

BIT
P20GT8
NLBNPIT20GT8 20240918 5100
LSE
0RQO
Bonesupport Holding Ab
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network